Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2016, Article ID 7164829, 4 pages
Case Report

Primary Cardiac Lymphoma: Lessons Learned from a Long Survivor

1Graduate Medical Education, St. John Hospital and Medical Center, Detroit, MI, USA
2Graduate Medical Education, St. John Macomb-Oakland Hospital, Detroit, MI, USA
3Van Elslander Cancer Center, Grosse Pointe Woods, MI, USA
4Lymphoma Research Lab., Wayne State University School of Medicine, Detroit, MI, USA

Received 12 May 2016; Accepted 25 September 2016

Academic Editor: Tayfun Sahin

Copyright © 2016 Baljit Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Primary cardiac lymphoma (PCL) is a rare neoplasm that involves the heart, pericardium, or both. Patients with PCL have median survival of approximately 7 months. We report a 63-year-old woman with PCL treated with chemoimmunotherapy but relapsed 7 years later. She received automated implantable cardioverter-defibrillator (AICD) prophylactically shortly after the diagnosis. She presented with a breast recidive 7 years after initial diagnosis and died of relapsed small cell lung cancer. As many patients with PCL die early in the disease course due to life-threatening arrhythmias, preemptive implantation of AICD may improve mortality and prevent early death. Chemoimmunotherapy is effective in inducing remission in patients with PCL. Late and unusual pattern of relapse may be more frequent in patients with PCL and should be explored further. This case presents one of the longest surviving patients with PCL reported in the literature.